Advertisement
Novara — A Smarter Way to Access Global Markets
LIVE DESK·Global markets desk

Markets

First Solar hits $183 low on 52-week low as analysts raise targets
EquitiesArticle

First Solar hits $183 low on 52-week low as analysts raise targets

First Solar Inc. trades at its lowest level in five years amid continued pressure, with analysts citing potential relief from Section 232 tariffs as a catalyst for recovery.

Priya Anand · 25 Sept 2026
Thalassa Holdings reports £0.36m loss in H1 2026 amid operational declines
EquitiesArticle

Thalassa Holdings reports £0.36m loss in H1 2026 amid operational declines

Investment firm reports year-over-year losses and reduced asset values, while key subsidiaries face delays and divestitures.

Priya Anand · 25 Sept 2026
Mobix Labs Raises Q4 Revenue Forecast to Exceed $1.6M
EquitiesArticle

Mobix Labs Raises Q4 Revenue Forecast to Exceed $1.6M

Irvine-based wireless connectivity firm reiterates guidance for a fiscal Q4 2026 revenue increase of over 100% sequentially, citing defense sector demand.

Priya Anand · 25 Sept 2026
Mettler-Toledo Stock Reaches 52-Week High on Q2 Earnings, Analyst Upgrades
EquitiesArticle

Mettler-Toledo Stock Reaches 52-Week High on Q2 Earnings, Analyst Upgrades

The precision instruments maker reported strong Q2 revenue growth and surpassed earnings estimates, prompting price target revisions from Wall Street analysts.

Priya Anand · 25 Sept 2026
Thermo Fisher Scientific Stock Surges to 52-Week High on Strong Q2 Results
EquitiesArticle

Thermo Fisher Scientific Stock Surges to 52-Week High on Strong Q2 Results

Life-sciences giant hits $671.69 as Q2 earnings and revenue beat estimates; UBS upgrades to Buy with double-digit EPS growth projected by 2027.

Priya Anand · 25 Sept 2026
Dom Pérignon launches its most limited 2017 vintage
CommoditiesArticle

Dom Pérignon launches its most limited 2017 vintage

LVMH’s Dom Pérignon releases the 2017 vintage, its most restricted edition, with an early harvest and a Chardonnay‑dominant blend.

David Chen · 25 Sept 2026
Agilent Technologies Stock Hits 52-Week High at $169.07
EquitiesArticle

Agilent Technologies Stock Hits 52-Week High at $169.07

Shares of Agilent Technologies reached a new 52-week high as Wall Street raises price targets on strong third-quarter results and upgraded outlook.

Priya Anand · 25 Sept 2026
Asian currencies slip as dollar climbs to two‑month high, yen tests 160
ForexArticle

Asian currencies slip as dollar climbs to two‑month high, yen tests 160

The dollar index edged up 0.2% in Asian trade after four straight days of gains, while the yen fell to its weakest level since early September and approached the 160‑per‑dollar mark. Other Asian currencies, led by the Australian dollar, also weakened amid higher U.S. Treasury yields and softer jobless claims.

Sophie Laurent · 25 Sept 2026
Asian Currencies Slide as Dollar Hits Two-Month High; Yen Nears 160
ForexArticle

Asian Currencies Slide as Dollar Hits Two-Month High; Yen Nears 160

Dollar extends win streak for fourth day amid surging Treasury yields; yen tests 159 as Japan's rate decision looms, while Aussie dollar leads regional losers on worsening employment data.

Sophie Laurent · 25 Sept 2026
Popular US Treasury ETF Hits Record Low on Bond Selloff
CommoditiesArticle

Popular US Treasury ETF Hits Record Low on Bond Selloff

BlackRock's iShares 20+ Year Treasury Bond ETF fell 1.6% to $80.46, erasing more than half its value since 2020 as Fed rate expectations weigh on long-duration bonds.

David Chen · 25 Sept 2026
US equities extend losses as oil prices and inflation fears weigh
EquitiesArticle

US equities extend losses as oil prices and inflation fears weigh

Dow Jones, S&P 500, Nasdaq all decline by 0.2–0.5% amid rising oil prices and geopolitical risks.

Priya Anand · 25 Sept 2026
Avalo Therapeutics Shares Climb on Hidradenitis Suppurativa Trial Data
ForexArticle

Avalo Therapeutics Shares Climb on Hidradenitis Suppurativa Trial Data

Avalo reported both doses of abdakibart met the primary endpoint in the LOTUS Phase II trial for hidradenitis suppurativa, paving the way for Phase III launches planned for the first half of 2027.

Sophie Laurent · 25 Sept 2026
Block Adds Bitcoin Lightning Support to x402 Payment Protocol for AI Agents
CryptoArticle

Block Adds Bitcoin Lightning Support to x402 Payment Protocol for AI Agents

The move enables AI agents to make low-cost, high-volume payments via Bitcoin Lightning, aligning Block with Google, Microsoft, AWS and Coinbase in backing the open x402 standard.

Marcus Webb · 25 Sept 2026
BlackRock HY Fund Drops 18.6% to $7.77 on 52-Week Low
EquitiesArticle

BlackRock HY Fund Drops 18.6% to $7.77 on 52-Week Low

The BlackRock Corporate High Yield Fund (HYT) fell to its lowest point in 2026 at $7.77, marking an 18.6% decline from its 52-week peak of $9.55.

Priya Anand · 25 Sept 2026
Hyperion DeFi Expands Data Feeds Partnership with DoubleZero for Hyperliquid Blockchain
CryptoArticle

Hyperion DeFi Expands Data Feeds Partnership with DoubleZero for Hyperliquid Blockchain

Hyperion DeFi secured a 10-million-token stake in DoubleZero Edge while collaborating on Hyperliquid’s launch of dedicated market data feeds, including perpetuals and RWA markets.

Marcus Webb · 25 Sept 2026
Twist Bioscience shares reach 52‑week high of $170.69
EquitiesArticle

Twist Bioscience shares reach 52‑week high of $170.69

The biotech firm’s stock surged to $170.69, up 527.55% over the past year and 400% YTD, as it announced a new partnership with Eli Lilly’s Lilly TuneLab and filed a prospectus supplement for a share resale.

Priya Anand · 25 Sept 2026
Gold edges lower, set for weekly loss as oil fuels Fed hike bets
CommoditiesArticle

Gold edges lower, set for weekly loss as oil fuels Fed hike bets

Gold posted a weekly decline exceeding 2% as rising oil prices and Treasury yields intensified expectations of additional Federal Reserve rate increases.

David Chen · 25 Sept 2026
Anavex elects six directors at annual stockholder meeting
EquitiesArticle

Anavex elects six directors at annual stockholder meeting

Anavex Life Sciences Corp. (NASDAQ: AVXL) reported preliminary results from its 2026 annual meeting, with all six board nominees elected. Final tabulation and an SEC Form 8-K are pending.

Priya Anand · 25 Sept 2026
Anavex stockholders elect six directors at annual meeting
EquitiesArticle

Anavex stockholders elect six directors at annual meeting

Shareholders of the clinical-stage biopharmaceutical company voted to reelect all six director nominees, with Dr. Jiong Ma retaining his role as independent chair.

Priya Anand · 25 Sept 2026